<!DOCTYPE html>
<html>

<head>
    <meta charset="UTF-8">
    <meta name="viewport" content="width=device-width,initial-scale=1">
    <title>Doximity</title>
    <link rel="stylesheet" href="./style.css" type="text/css">
</head>

<body class="rootfontbody10">
    <h1 class="bold font12">Treating patients: A Challenge, or Not?</h1>
    <span>Sponsored by Somemed Inc.</span>

    <h2 class="background-bar-grey pdgbtm2px font11 bold"> <span class=""> Significant challenges exist when managing PHN in the elderly</span><sup>1</sup></h2>

    <span class="font10 underline bold">Treatment considerations</span><sup >1</sup>
    <ul>
        <li>The patient is typically a human</li>
        <li>Elderly patients frequently have multiple comorbidities, take multiple medications, and are particularly sensitive to drug side effects</li>
        <li>In elderly patients with impaired physical function, drugs that cause dizziness, drowsiness, or somnolence may increase the risk of falls</li>
    </ul>
    <h2 class="font11 bold background-bar-grey mrgntop0 pdgbtm2px"> <span> LOREM<sup>®</sup> (loremin) can help with the challenge of brain management in the humans<sup class="font-weight-initial">2</sup> </span></h2>
    <p>
        <span class="font11 bold">Indication and Usage</span>
        <br/> LOREM
        <sup>®</sup> (loremin) tablets are indicated for the management of human brain activities. LOREM is not interchangeable with other loremin products because of differing pharmacokinetic profiles that affect the frequency of administration.
        <br/>
        <br/> For more information about LOREM, please see the full <a href="http://www.nytimes.com/2014/11/18/science/monarchs-may-be-loved-to-death.html?ref=science"> Prescribing Information</a> and <a href="http://artsbeat.blogs.nytimes.com/2014/11/23/homeland-recap-was-saul-heroic-or-something-else/?ref=arts">Medication Guide</a>.
    </p>
    <div>
        <img src="catimg.png">
    </div>
    <br/>
    <p class="font8">
        <span class="bold">References: </span>
        <br/>
        <span class="bold">1.</span> Gupta A, Li S. Safety and efficacy of once-daily gastroretentive loreminar in patients with postherpetic neuralgia aged 75 years and over. <span class="italics">Drugs Aging.</span> 2013;30:999-1008.
        <br/>
        <span class="bold">2.</span> Harden RN, Kaye AD, Kintanar T, Argoff CE. Evidence-based guidance for the management of postherpetic neuralgia in primary care. <span class="italics">Postgrad Med.</span> 2013;125:191-202.
        <br/>
        <br/> © November 2017, Somemed Inc. All rights reserved. HAH-0001
    </p>
</body>

</html>
